Page 8 - Meissa Vaccines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How Intranasal COVID Vaccines Could Be Holy Grail of Vaccination

How Intranasal COVID Vaccines Could Be Holy Grail of Vaccination
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

University of washingtonUnited statesCiudad de la habanaUniversity of alabamaFrances lundTroyd randallDivision of clinical immunologyUniversity of oxfordMedscape coronavirus resource centerUniversity of hong kongDivision of infectious diseasesWashington national primate research centerUniversity of washington school medicineAtimmune incA team of first respondersDepartment of medicine

A spritz instead of a jab? Future COVID-19 vaccines may go up your nose

A spritz instead of a jab? Future COVID-19 vaccines may go up your nose
nationalgeographic.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationalgeographic.co.uk Daily Mail and Mail on Sunday newspapers.

United statesDavid curielDonna farberMarcus buggertPaul mccrayKarolinska instituteHarvard universityColombia universityUniversity of iowaWashington university in stAmerican society for virologyAmerican societyMeissa vaccinesScience advancesWashington universityVon andrian

Scent of a vaccine

Scent of a vaccine
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.

Drug administrationUniversity of hong kongVaccine elicited igaHong kongMeissa vaccinesபல்கலைக்கழகம் ஆஃப் ஹாங் காங்ஹாங் காங்மேஸ்ஸ தடுப்பு மருந்துகள்

A spritz instead of a jab? Future COVID-19 vaccines may go up your nose

A spritz instead of a jab? Future COVID-19 vaccines may go up your nose
nationalgeographic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationalgeographic.com Daily Mail and Mail on Sunday newspapers.

Meissa Announces Preclinical Data on Intranasal COVID-19 Vaccine Showing Protection from SARS-CoV-2 Challenge after a Single Dose

Press release content from Business Wire. The AP news staff was not involved in its creation. Meissa Announces Preclinical Data on Intranasal COVID-19 Vaccine Showing Protection from SARS-CoV-2 Challenge after a Single Dose July 20, 2021 GMT REDWOOD CITY, Calif. (BUSINESS WIRE) Jul 19, 2021 Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today the release of preclinical data in nonhuman primates (NHPs) of the company’s intranasal recombinant live attenuated COVID-19 vaccine (MV-014-212). The data demonstrate that a single adjuvant-free dose of MV-014-212 provided equivalent protection against SARS-CoV-2 challenge compared to reported efficacy in NHP models of currently authorized vaccines. Furthermore, the data show that MV-014-212 stimulates mucosal (nasal IgA) antibodies in the upper respiratory tract, the major infection route for SARS-CoV-2, and systemic (serum neutralizing and binding I

South africaUnited statesUnited kingdomRedwood cityRoderick tangJessica yinglingMartin mooreMariana tioniBill dalyMeissa attenublockEmory universityLittle dog communicationsChief scientific officerMeissa contactsClinical trialsChief business officer